President A1 bought a stake in one of the largest pharmaceutical distributors

Partner Of Rostec

The President of A1 investment company that manages funds of shareholders of “Alfa-group”, Alexander Vinokurov has acquired a large stake in a pharmaceutical distributor “SIA international” from the heirs of company founder Igor Rudinskaya, said Sunday the branch editions Vademecum and “Pharmaceutical Bulletin”.

According to the Vademecum, the family of the founder “SIA Internejshnl” Igor Rudinskaya, who died in October 2014, have reached a principal agreement with Vinokurov, he will be co-investing in pharmaceutical companies. According to the publication, Vinokurov can get “50% or a little more”.

“Pharmaceutical Bulletin”, citing a source close to the negotiations, said that the heirs Rudinskaya will retain part of the business.

Representative Alexander Vinokourov has confirmed that he bought a stake in SIA, without revealing other details. To receive comments in “SIA international” on Sunday night failed.

Alexander Vinokourov and his father Seeds Vinokourov already have assets in the pharmaceutical business, said, “the Pharmaceutical Bulletin”: they are co-owners of the distribution company “Genta”, which has a joint venture with a subsidiary of Rostec “Natimbi”.

Forbes magazine has included 33-year-old Alexander Vinokurov in the list of highest paid young executives. He started his career in 2003 as a trainee in the investment Bank Morgan Stanley, and three years later became the co-Director of the Russian office of TPG Capital Fund.

In 2008 he married the daughter of the Minister of foreign Affairs of the Russian Federation Sergey Lavrov.

In the summer of 2011 became the first Vice President of Summa group of Ziyavudin Magomedov, then, in 2012 – President of the company. At the end of 2014 was the head of investment company A1.

Instead of “R-Pharm”

In the ranking of the largest pharmaceutical distributors in Russia, compiled RNC Pharma for the first nine months of 2015, “SIA international” took 7-th place with market share of 7.6% (over the same period of the previous year the company’s share was 8.1%).

The intention to buy the “SIA international” in 2014, said another large pharmaceutical distributor — “R-Pharm” (5-th place in the rating). But in November last year the General Director of “R-Pharm” Vasily Ignatyev said that the decision to purchase is delayed until 2016: the buyer had intended to examine the financial results of “SIA international” by the end of 2015 and then make a decision.

According to SPARK, the revenues of CJSC “SIA international Ltd” in 2014 amounted to 98.5 bn — more than 30% higher than in 2013. the company’s Net profit in 2014 — almost 144 million roubles.